Blench IP - Search Results

1

High-sensitivity FAB-MS strategies for O-GlcNAc characterization.

Reason AJ, Blench IP, Haltiwanger RS, Hart GW, Morris HR, Panico M, Dell A. Reason AJ, et al. Among authors: blench ip. Glycobiology. 1991 Dec;1(6):585-94. doi: 10.1093/glycob/1.6.585. Glycobiology. 1991. PMID: 1822238

2

Isolation, purification and characterization of beta-hCGRP from human spinal cord.

Wimalawansa SJ, Morris HR, Etienne A, Blench I, Panico M, MacIntyre I. Wimalawansa SJ, et al. Biochem Biophys Res Commun. 1990 Mar 30;167(3):993-1000. doi: 10.1016/0006-291x(90)90621-s. Biochem Biophys Res Commun. 1990. PMID: 2322288

3

Discovery of a novel protein modification: alpha-glycerophosphate is a substituent of meningococcal pilin.

Stimson E, Virji M, Barker S, Panico M, Blench I, Saunders J, Payne G, Moxon ER, Dell A, Morris HR. Stimson E, et al. Biochem J. 1996 May 15;316 ( Pt 1)(Pt 1):29-33. doi: 10.1042/bj3160029. Biochem J. 1996. PMID: 8645220 Free PMC article.

4

Arthrobacter D-xylose isomerase: partial proteolysis with thermolysin.

Siddiqui KS, Rangarajan M, Hartley BS, Kitmitto A, Panico M, Blench IP, Morris HR. Siddiqui KS, et al. Among authors: blench ip. Biochem J. 1993 Jan 1;289 ( Pt 1)(Pt 1):201-8. doi: 10.1042/bj2890201. Biochem J. 1993. PMID: 8424759 Free PMC article.

5

Synergistic interaction of growth factors and albumin in regulating estradiol synthesis in breast cancer cells.

Singh A, Blench I, Morris HR, Savoy LA, Reed MJ. Singh A, et al. Mol Cell Endocrinol. 1992 Jun;85(3):165-73. doi: 10.1016/0303-7207(92)90255-5. Mol Cell Endocrinol. 1992. PMID: 1634015

6

Identification of albumin in breast tumor cytosol as a factor involved in the stimulation of estradiol 17 beta-hydroxysteroid dehydrogenase (reductive) activity.

Singh A, Ghilchik MW, Patel SR, Blench I, Morris HR, Reed MJ. Singh A, et al. Mol Cell Endocrinol. 1992 Jan;83(1):85-92. doi: 10.1016/0303-7207(92)90199-g. Mol Cell Endocrinol. 1992. PMID: 1551473

7

Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate.

Caso R, Lane DA, Thompson EA, Olds RJ, Thein SL, Panico M, Blench I, Morris HR, Freyssinet JM, Aiach M, et al. Caso R, et al. Br J Haematol. 1991 Jan;77(1):87-92. doi: 10.1111/j.1365-2141.1991.tb07953.x. Br J Haematol. 1991. PMID: 1998601

8

Formation of a covalent disulfide-linked antithrombin-albumin complex by an antithrombin variant, antithrombin "Northwick Park".

Erdjument H, Lane DA, Ireland H, Panico M, Di Marzo V, Blench I, Morris HR. Erdjument H, et al. J Biol Chem. 1987 Oct 5;262(28):13381-4. J Biol Chem. 1987. PMID: 3654616 Free article.

9

Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.

Ireland H, Lane DA, Thompson E, Walker ID, Blench I, Morris HR, Freyssinet JM, Grunebaum L, Olds R, Thein SL. Ireland H, et al. Br J Haematol. 1991 Sep;79(1):70-4. doi: 10.1111/j.1365-2141.1991.tb08009.x. Br J Haematol. 1991. PMID: 1911389

10

Sequence and structure of a human glucose transporter.

Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, Morris HR, Allard WJ, Lienhard GE, Lodish HF. Mueckler M, et al. Science. 1985 Sep 6;229(4717):941-5. doi: 10.1126/science.3839598. Science. 1985. PMID: 3839598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters